3D chamber reconstruction, activation & voltage mapping, and precision localization of an arrhythmia's critical site for ablation
Before any electrical data can be interpreted, the mapping system must know the anatomy it is working with. A steerable, multi-electrode catheter is advanced into the cardiac chamber and swept systematically across the endocardial (or epicardial) surface. A magnetic-field or impedance-based localization engine tracks the catheter tip in 3D space at sub-millimeter accuracy, and every contact point becomes a vertex of a growing anatomic shell — a patient-specific 3D model built entirely from real catheter contact, not a generic template.
Modern electroanatomical mapping (EAM) systems — such as impedance/magnetic hybrid platforms — combine two complementary localization principles:
• Magnetic field sensing: a coil at the catheter tip senses a low-strength magnetic field generated by external field generators beneath the patient. Triangulation of field strength gives absolute 3D position with sub-millimeter precision, independent of fluoroscopy.
• Impedance-based localization: small currents are passed between skin patches and the catheter; local impedance gradients allow additional catheters (without magnetic sensors) to be visualized on the same 3D map, dramatically increasing point-collection throughput.
As the operator drags the catheter across the endocardium, each stable contact point is logged as a 3D coordinate. A surface-fitting algorithm (typically a fast marching / convex-hull-based mesh) interpolates between acquired points to render a continuous anatomic shell, updated live as more points are added.
The fidelity of the reconstructed chamber — and every downstream color map layered onto it — depends directly on how many points were acquired and how evenly they cover the chamber surface. Sparse point clouds force the interpolation algorithm to guess across large gaps, which can smear over small but clinically important structures such as a narrow scar channel or a localized area of slow conduction.
Operators therefore aim not just for a high point count, but for even coverage: dense sampling in regions of anatomic complexity (pulmonary vein ostia, valve annuli, scar borders) and adequate — not necessarily exhaustive — sampling of smooth, electrically uniform walls.
A geometry built from too few or unevenly distributed points can misrepresent chamber shape by several millimeters — enough to place a later ablation lesion in the wrong location relative to the true anatomic target.
A 3D shell alone carries no electrical information. The defining innovation of electroanatomical mapping is that every single spatial point is captured together with its local electrical signal — the unipolar and bipolar electrogram recorded at that exact catheter position. This tight anatomy-to-signal linkage is what allows the system to later paint activation timing, voltage, and other electrical properties directly onto the 3D chamber surface.
Two signal types are recorded at every point, and both carry distinct diagnostic information:
• Unipolar electrogram: recorded between one mapping electrode and a distant reference (e.g. Wilson central terminal). Its morphology — particularly a sharp negative (QS) deflection — indicates the moment the activation wavefront passes directly beneath that electrode, giving precise local activation timing.
• Bipolar electrogram: the voltage difference between two closely spaced electrodes on the catheter tip. Because far-field signals cancel out, bipolar amplitude is a clean, localized measure of tissue health — the basis of the voltage map used later to identify scar.
Both signals are digitized simultaneously with the 3D coordinate, so each vertex of the anatomic shell carries a complete electrical fingerprint from the moment it is acquired.
Not every catheter contact produces a usable point. Modern mapping systems apply automated gating criteria before a point is accepted into the map:
• Stability criteria: catheter position and cycle length must remain stable for a minimum number of beats, rejecting points collected during catheter motion or ectopy. • Contact-force sensing: many catheters report real-time tissue contact force (grams); points below a minimum threshold (~3–5 g) are flagged as low-confidence, since poor contact distorts electrogram amplitude and timing. • Signal-to-noise thresholds: electrograms with excessive noise or saturation are automatically excluded.
This automated filtering is what allows systems to acquire hundreds of points per minute during multi-electrode sweeps while keeping the resulting map electrically trustworthy.
With every point carrying a precise local activation time (LAT), the system can color the entire chamber surface by timing relative to a fixed reference — typically a stable intracardiac reference electrogram or the onset of the surface QRS. The result is an isochronal (equal-time) color map: red for the earliest-activated tissue, progressing through orange, yellow, green, and blue for the latest — a direct visualization of how the depolarization wavefront sweeps across the chamber.
Because activation timing is only meaningful relative to a fixed point in the cardiac cycle, the operator first selects a stable reference channel — often a coronary sinus catheter electrode or a fixed surface ECG fiducial. Every mapped point's local activation time (the sharpest deflection in its unipolar electrogram) is then expressed as a millisecond offset from that reference, positive or negative.
For a focal arrhythmia, the activation window spans from the earliest to the latest activated point across the whole chamber. For a reentrant arrhythmia, the "window of interest" instead spans one full tachycardia cycle length, since activation is continuous and circular rather than radiating outward from a single point.
The color gradient itself tells a mechanistic story:
• Focal pattern: a single red "earliest" point with concentric, evenly-spaced isochrones radiating outward in all directions — characteristic of a focal trigger (e.g. a pulmonary vein ectopic focus).
• Macro-reentry pattern: the earliest (red) and latest (blue) colors sit immediately adjacent to one another (early meets late) — because the wavefront has traveled the entire chamber and returned to nearly where it started, forming a continuous circuit rather than a radiating pattern.
• Crowded isochrones: tightly packed color bands over a short distance indicate a zone of slow conduction — frequently the "protected isthmus" of a reentry circuit and a prime ablation target.
Isochronal crowding — many color bands compressed into just a few millimeters — is one of the most reliable visual signatures of a critical, ablatable slow-conduction channel.
Activation timing shows how the current arrhythmia behaves, but voltage mapping reveals the underlying anatomic substrate that makes an arrhythmia possible in the first place. By re-coloring the same acquired points using bipolar signal amplitude instead of timing, the system exposes areas of scar or fibrotic, non-conducting tissue — regions where healthy myocardium has been replaced and electrical continuity is impaired.
Bipolar voltage reflects the amount of viable, electrically active myocardial tissue directly beneath the recording electrodes. Fibrotic scar — whether from prior infarction, cardiomyopathy, or surgical incision — replaces contractile, conducting cells with electrically inert connective tissue. Where scar dominates, the bipolar signal amplitude collapses.
Because bipolar recording cancels far-field signal (unlike unipolar), a low bipolar voltage is a specific, localized marker: it means the tissue immediately under the catheter tip — not tissue elsewhere in the chamber — has lost its electrical viability. This specificity is what makes voltage mapping the clinical standard for scar delineation.
Dense scar itself is electrically silent and cannot conduct an arrhythmia. The clinically important structures instead live at the scar's edges and within it:
• Border zone: the 0.5–1.5 mV rim surrounding dense scar, where surviving myocyte bundles are interspersed with fibrosis — conduction here is slow and anisotropic, the classic ingredient for reentry.
• Channels within scar: narrow corridors of surviving, low-but-nonzero voltage tissue that thread through an otherwise dense scar region, capable of conducting a slow, protected wavefront — often the exact isthmus a reentrant circuit uses.
Overlaying the voltage map with the activation map from Stage 3 is what allows an operator to confirm that a given anatomic channel is not just structurally present, but electrically active during the arrhythmia — the strongest possible evidence for an ablation target.
Voltage mapping alone identifies where scar could support an arrhythmia; only combining it with activation timing confirms where the arrhythmia is actually using that scar.
The final step fuses everything acquired so far — chamber geometry, activation timing, and voltage substrate — into a single composite interpretation that identifies the arrhythmia's critical site: the smallest region where an ablation lesion is most likely to permanently eliminate the arrhythmia. This is the entire clinical payoff of electroanatomical mapping — turning thousands of individual data points into one precise, actionable target.
Composite mapping generally reveals one of three mechanistic patterns, each with a distinct ablation strategy:
• Focal trigger: a single point of earliest activation with no associated voltage abnormality — often an ectopic focus in muscular tissue (e.g. a pulmonary vein sleeve). Ablation is applied directly at, or electrically isolating, that focal point.
• Macro-reentry circuit: a continuous loop of activation around a fixed anatomic or scar-related obstacle. The target is not a single point but the circuit's narrowest, most protected segment — ablating anywhere along a true critical isthmus interrupts the entire loop.
• Scar-related channel: a surviving conducting corridor threading through dense scar, identified where crowded isochrones (Stage 3) overlap a low-voltage channel (Stage 4). This overlap is the most specific composite signature of an ablatable substrate.
Once a candidate site is identified on the composite map, it is typically confirmed with targeted maneuvers before any lesion is delivered:
• Entrainment mapping: pacing from the candidate site and comparing the resulting activation pattern to the native tachycardia — a matching pattern with a short post-pacing interval confirms the site lies within the reentry circuit. • Pace-mapping: for focal triggers, pacing from the candidate site should reproduce the same surface ECG morphology as the spontaneous arrhythmia.
Once confirmed, radiofrequency or cryoablation energy is delivered at the exact 3D coordinate on the map, and the mapping system tags the lesion in place — allowing the operator to build a contiguous line or ring of lesions and immediately verify, on the very same 3D model, whether the targeted electrical pathway has been abolished.
Because the ablation catheter is tracked on the same 3D system used to build the map, every delivered lesion is recorded at sub-millimeter accuracy relative to the original activation and voltage data — closing the loop from diagnosis to therapy on a single anatomic model.